# Klinik und Poliklinik für Urologie

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/klinik-und-poliklinik-fur-urologie/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 81 |
| Citations | 150,231 |
| City | Dresden |
| Country | DE |
| Description | Klinik und Poliklinik für Urologie is a research organisation in Dresden, DE. OpenAlex records 9,177 works and 150,231 citations for it. 2,060 researchers list it as their most recent affiliation. |
| Homepage | https://www.uniklinikum-dresden.de/de/das-klinikum/kliniken-polikliniken-institute/uro |
| OpenAlex ID | https://openalex.org/I4210086080 |
| Researchers | 2,060 |
| ROR ID | https://ror.org/00gfym921 |
| Type | healthcare |
| Works | 9,177 |

## University papers

- [MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis](https://scholariq.org/papers/mri-targeted-or-standard-biopsy-for-prostate-cancer-diagnosis/)
- [Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT](https://scholariq.org/papers/prostate-cancer-molecular-imaging-standardized-evaluation-promise-proposed-mitnm/)
- [Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group](https://scholariq.org/papers/standards-of-reporting-for-mri-targeted-biopsy-studies-start-of-the-prostate/)
- [ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder](https://scholariq.org/papers/icud-eau-international-consultation-on-bladder-cancer-2012-radical-cystectomy/)
- [Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/addition-of-radium-223-to-abiraterone-acetate-and-prednisone-or-prednisolone-in/)
- [Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer](https://scholariq.org/papers/randomized-open-label-phase-iii-trial-of-docetaxel-plus-high-dose-calcitriol/)

## University top topics

Showing 8 of 24.

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urological Disorders and Treatments](https://scholariq.org/topics/urological-disorders-and-treatments/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)
- [Pediatric Urology and Nephrology Studies](https://scholariq.org/topics/pediatric-urology-and-nephrology-studies/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.